<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>33(1)</volume><submitter>Lai EF</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Few studies have compared within-patient variability measures of tacrolimus trough levels by formulation and assessed within-patient variability on outcomes of kidney transplant recipients.&lt;h4>Research questions&lt;/h4>(1) To compare within-patient variability of trough levels when converting from twice-daily to once-daily tacrolimus using standard deviation, coefficient of variation, and intrapatient variability percent. (2) To use the 3 measures of variability to examine the relationship between tacrolimus once-daily within-patient variability and total graft failure (i.e., return to chronic dialysis, pre-emptive retransplant, death with graft function).&lt;h4>Design&lt;/h4>In this observational cohort study, within-patient variability of trough levels pre- and post-conversio</pubmed_abstract><journal>Progress in transplantation (Aliso Viejo, Calif.)</journal><pagination>34-42</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9968997</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Tacrolimus Formulation, Exposure Variability, and Outcomes in Kidney Transplant Recipients.</pubmed_title><pmcid>PMC9968997</pmcid><pubmed_authors>Famure O</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Lai EF</pubmed_authors><pubmed_authors>Kim SJ</pubmed_authors><pubmed_authors>Nguyen HT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tacrolimus Formulation, Exposure Variability, and Outcomes in Kidney Transplant Recipients.</name><description>&lt;h4>Introduction&lt;/h4>Few studies have compared within-patient variability measures of tacrolimus trough levels by formulation and assessed within-patient variability on outcomes of kidney transplant recipients.&lt;h4>Research questions&lt;/h4>(1) To compare within-patient variability of trough levels when converting from twice-daily to once-daily tacrolimus using standard deviation, coefficient of variation, and intrapatient variability percent. (2) To use the 3 measures of variability to examine the relationship between tacrolimus once-daily within-patient variability and total graft failure (i.e., return to chronic dialysis, pre-emptive retransplant, death with graft function).&lt;h4>Design&lt;/h4>In this observational cohort study, within-patient variability of trough levels pre- and post-conversio</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2025-04-04T21:48:11.588Z</modification><creation>2025-04-04T21:48:11.588Z</creation></dates><accession>S-EPMC9968997</accession><cross_references><pubmed>36562176</pubmed><doi>10.1177/15269248221145044</doi></cross_references></HashMap>